BP can arise as a primary idiopathic disorder (classic BP, cBP) or in association with pharmacologic treatment using dipeptidyl-peptidase 4 (DPP4) inhibitors, commonly known as gliptins, used in the management of type 2 diabetes (DPP4i-associated BP) [4]. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.